These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10422655)

  • 1. Differential effects of low dose CP122,288 and eletriptan on fos expression due to stimulation of the superior sagittal sinus in cat.
    Goadsby PJ; Hoskin KL
    Pain; 1999 Jul; 82(1):15-22. PubMed ID: 10422655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of calcitonin gene-related peptide release after superior sagittal sinus stimulation in cat: a comparison of avitriptan and CP122,288.
    Knight YE; Edvinsson L; Goadsby PJ
    Neuropeptides; 1999 Feb; 33(1):41-6. PubMed ID: 10657470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance P blockade with the potent and centrally acting antagonist GR205171 does not effect central trigeminal activity with superior sagittal sinus stimulation.
    Goadsby PJ; Hoskin KL; Knight YE
    Neuroscience; 1998 Sep; 86(1):337-43. PubMed ID: 9692766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4991W93 inhibits release of calcitonin gene-related peptide in the cat but only at doses with 5HT(1B/1D) receptor agonist activity?
    Knight YE; Edvinsson L; Goadsby PJ
    Neuropharmacology; 2001 Mar; 40(4):520-5. PubMed ID: 11249961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of more and less lipophilic serotonin (5HT1B/1D) agonists in a model of trigeminovascular nociception in cat.
    Hoskin KL; Goadsby PJ
    Exp Neurol; 1998 Mar; 150(1):45-51. PubMed ID: 9514827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of trigeminal neurones after intravenous administration of naratriptan through an action at 5-hydroxy-tryptamine (5-HT(1B/1D)) receptors.
    Goadsby PJ; Knight Y
    Br J Pharmacol; 1997 Nov; 122(5):918-22. PubMed ID: 9384509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fos expression in the trigeminocervical complex of the cat after stimulation of the superior sagittal sinus is reduced by L-NAME.
    Hoskin KL; Bulmer DC; Goadsby PJ
    Neurosci Lett; 1999 May; 266(3):173-6. PubMed ID: 10465701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microiontophoretic application of serotonin (5HT)1B/1D agonists inhibits trigeminal cell firing in the cat.
    Storer RJ; Goadsby PJ
    Brain; 1997 Dec; 120 ( Pt 12)():2171-7. PubMed ID: 9448572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine?
    Goadsby PJ; Hoskin KL
    Pain; 1996 Oct; 67(2-3):355-9. PubMed ID: 8951929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of eletriptan on the peptidergic innervation of the cerebral dura mater and trigeminal ganglion, and on the expression of c-fos and c-jun in the trigeminal complex of the rat in an experimental migraine model.
    Knyihár-Csillik E; Tajti J; Csillik AE; Chadaide Z; Mihály A; Vécsei L
    Eur J Neurosci; 2000 Nov; 12(11):3991-4002. PubMed ID: 11069595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The in vivo pharmacological profile of eletriptan (UK-116,044): a potent and novel 5-HT(1B/1D) receptor agonist.
    Gupta P; Butler P; Shepperson NB; McHarg A
    Eur J Pharmacol; 2000 Jun; 398(1):73-81. PubMed ID: 10856450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee.
    Goadsby PJ; Ferrari MD; Olesen J; Stovner LJ; Senard JM; Jackson NC; Poole PH
    Neurology; 2000 Jan; 54(1):156-63. PubMed ID: 10636142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-clinical pharmacology of zolmitriptan (Zomig; formerly 311C90), a centrally and peripherally acting 5HT1B/1D agonist for migraine.
    Martin GR
    Cephalalgia; 1997 Oct; 17 Suppl 18():4-14. PubMed ID: 9399012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin inhibits trigeminal nucleus activity evoked by craniovascular stimulation through a 5HT1B/1D receptor: a central action in migraine?
    Goadsby PJ; Hoskin KL
    Ann Neurol; 1998 Jun; 43(6):711-8. PubMed ID: 9629840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges.
    Nozaki K; Moskowitz MA; Boccalini P
    Br J Pharmacol; 1992 Jun; 106(2):409-15. PubMed ID: 1327382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sumatriptan can inhibit trigeminal afferents by an exclusively neural mechanism.
    Hoskin KL; Kaube H; Goadsby PJ
    Brain; 1996 Oct; 119 ( Pt 5)():1419-28. PubMed ID: 8931567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 5-hydroxytryptamine1B/1D/1F receptor agonists eletriptan and naratriptan inhibit trigeminovascular input to the nucleus tractus solitarius in the cat.
    Hoskin KL; Lambert GA; Donaldson C; Zagami AS
    Brain Res; 2004 Feb; 998(1):91-9. PubMed ID: 14725972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Hydroxytryptamine(1B/1D) and 5-hydroxytryptamine1F receptors inhibit capsaicin-induced c-fos immunoreactivity within mouse trigeminal nucleus caudalis.
    Mitsikostas DD; Sanchez del Rio M; Waeber C
    Cephalalgia; 2002 Jun; 22(5):384-94. PubMed ID: 12110114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vivo pharmacological profile of a 5-HT1 receptor agonist, CP-122,288, a selective inhibitor of neurogenic inflammation.
    Gupta P; Brown D; Butler P; Ellis P; Grayson KL; Land GC; Macor JE; Robson SF; Wythes MJ; Shepperson NB
    Br J Pharmacol; 1995 Nov; 116(5):2385-90. PubMed ID: 8581273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression by the sumatriptan analogue, CP-122,288 of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin.
    Cutrer FM; Schoenfeld D; Limmroth V; Panahian N; Moskowitz MA
    Br J Pharmacol; 1995 Mar; 114(5):987-92. PubMed ID: 7780655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.